A new trial taking place at St. Joseph's Hospital in London, Ontario is currently recruiting patients to trial introducing RepHresh Pro-B, a probiotic natural health product to lower inflammation and risk of cancer. Women at high risk of developing breast cancer over the course of their lifetime who have not yet been diagnosed with the disease are eligible. According to the principle investigators, the goal of the trial is to "test [the] theory that taking probiotic lactobacilli by mouth can lead to these organisms reaching the breast tissue and help...reduce inflammation which has close links to cancer."
To read more about this trial, click here.
No comments:
Post a Comment